| 1 | [SID17508906] | Active | Potency | 0.1259 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 0.1259 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 2 | [SID17508906] | Active | Potency | 3.1623 | Quantitative High-Throughput Screen for Regulators of Epigenetic Control [AID1865, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | Quantitative High-Throughput Screen for Regulators of Epigenetic Control | | AID | 1865 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID17508906] | Active | Potency | 4.6109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID17508906] | Active | Potency | 4.6109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID17508906] | Active | Potency | 4.6109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID17508906] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID17508906] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID17508906] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID17508906] | Active | Potency | 6.5131 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 10 | [SID17508906] | Active | Potency | 10 | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 11 | [SID17508906] | Active | Potency | 14.0441 | qHTS for inhibitors of Vif-A3F interactions: Cherry picks [AID651814, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 14.0441 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3F interactions: Cherry picks | | AID | 651814 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 12 | [SID17508906] | Active | Potency | 15.7578 | qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen [AID651815, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 15.7578 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen | | AID | 651815 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 13 | [SID17508906] | Active | Potency | 15.7578 | qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen [AID651813, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 15.7578 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen | | AID | 651813 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 14 | [SID17508906] | Active | Potency | 17.6805 | qHTS for inhibitors of Vif-A3G interactions: Cherry picks [AID651812, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | Potency | 17.6805 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3G interactions: Cherry picks | | AID | 651812 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 15 | [SID17508906] | Active | EC50 | 25.202 | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response [AID1047, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | EC50 | 25.202 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response | | AID | 1047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID17508906] | Active | EC50 | 560.091 | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response [AID1045, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | EC50 | 560.091 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response | | AID | 1045 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID17508906] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID17508906] | Active | | | Counterscreen for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF): Fluorescence-based biochemical assay to identify fluorescence artifacts [AID504382, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Counterscreen for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF): Fluorescence-based biochemical assay to identify fluorescence artifacts | | AID | 504382 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID17508906] | Active | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID17508906] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 21 | [SID17508906] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 22 | [SID17508906] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 23 | [SID17508906] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 24 | [SID17508906] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID17508906] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 26 | [SID17508906] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 27 | [SID17508906] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 28 | [SID17508906] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 29 | [SID17508906] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 30 | [SID17508906] | Active | | | uHTS of Mcl-1/Bid interaction inhibitors [AID1021, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Bid interaction inhibitors | | AID | 1021 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 31 | [SID17508906] | Active | | | uHTS of Mcl-1/Bid interaction inhibitors [AID1021, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Bid interaction inhibitors | | AID | 1021 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 32 | [SID17508906] | Active | | | uHTS of Mcl-1/Bid interaction inhibitors [AID1021, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Bid interaction inhibitors | | AID | 1021 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 33 | [SID17508906] | Active | | | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) [AID602192, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) | | AID | 602192 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 34 | [SID17508906] | Active | | | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) [AID602192, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) | | AID | 602192 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 35 | [SID17508906] | Active | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | COPS5 gene product [Homo sapiens] [gi:38027923] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | COPS5 gene product [Homo sapiens] [gi:38027923] | | PubMed | | | Data Table |  |
|
| 36 | [SID17508906] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID504383, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 504383 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 37 | [SID17508906] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493008, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493008 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 38 | [SID17508906] | Active | | | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. [AID2153, Type: screening] | unnamed protein product [Aspergillus oryzae] [gi:83774548] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. | | AID | 2153 | | BioAssay type | screening | | Target | unnamed protein product [Aspergillus oryzae] [gi:83774548] | | PubMed | | | Data Table |  |
|
| 39 | [SID17508906] | Active | | | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. [AID2153, Type: screening] | unnamed protein product [Aspergillus oryzae] [gi:83774548] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. | | AID | 2153 | | BioAssay type | screening | | Target | unnamed protein product [Aspergillus oryzae] [gi:83774548] | | PubMed | | | Data Table |  |
|
| 40 | [SID17508906] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). [AID2149, Type: screening] | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). | | AID | 2149 | | BioAssay type | screening | | Target | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] | | PubMed | | | Data Table |  |
|
| 41 | [SID17508906] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). [AID1962, Type: screening] | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). | | AID | 1962 | | BioAssay type | screening | | Target | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] | | PubMed | | | Data Table |  |
|
| 42 | [SID17508906] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 43 | [SID17508906] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 44 | [SID17508906] | Inactive | Potency | 2.5119 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Inactive | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 45 | [SID17508906] | Inactive | Potency | 3.1623 | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding [AID2675, Type: confirmatory] | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Inactive | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding | | AID | 2675 | | BioAssay type | confirmatory | | Target | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] | | PubMed | | | Data Table |  |
|
| 46 | [SID17508906] | Inactive | Potency | 11.2202 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Inactive | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 47 | [SID17508906] | Inactive | Potency | 17.7828 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 48 | [SID17508906] | Inactive | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 49 | [SID17508906] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 50 | [SID17508906] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17508906 | | CID | 5769210 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|